Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2758.0000 31.10 (1.14%)
NSE Dec 31, 2025 11:18 AM
Volume: 15,023
High vol. this week

logo
Ajanta Pharma Ltd.
04 Nov 2025
2758.00
1.14%
ICICI Direct
Q2FY26- Momentum driven by US and India Business - Revenues grew ~14% YoY to 1354 crore driven by US and India branded business which grew ~48% / ~12% to 344 crore and 432 crore, respectively. Other branded businesses such as Asia and Africa witnessed the growth of 5% / 4% (on higher base) to 310 crore and 221 crore, respectively. On the operational front, EBITDA grew 5.4% YoY to ~328 crore (excluding forex losses of 41 crore, 9 % growth to ~369 crore) with margins at 24.2%...
Number of FII/FPI investors decreased from 371 to 343 in Sep 2025 qtr
More from Ajanta Pharma Ltd.
Recommended